Neuroendocrine control of metabolism

References

• Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol 2009;53:120–128.
   PubMed Web of Science ®Google Scholar
• Gross PM. Circumventricular organ capillaries. Prog Brain Res 1992;91:219–233.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010;57:359–372.
   PubMed Web of Science ®Google Scholar
• Zac-Varghese S, Tan T, Bloom SR. Hormonal interactions between gut and brain. Discov Med 2010;10:543–552.
   Google Scholar
• Leibowitz SF, Hammer NJ, Chang K. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol Behav 1981;27:1031–1040.
   PubMed Web of Science ®Google Scholar
• Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev 2006;27:736–749.
   PubMed Web of Science ®Google Scholar
• Tao YX. Molecular mechanisms of the neural melanocortin receptor dysfynction in severe early onset obesity. Mol Cell Endocrinol 2005;239:1–14.
   PubMed Web of Science ®Google Scholar
• Abbott CR, Rossi M, Wren AM, Murphy KG, Kennedy AR, Stanley SA, Zollner AN, et al. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 2001;142:3457–3463.
   PubMed Web of Science ®Google Scholar
• Wynne K, Stanley S, McGowan B, Bloom S. Appetite control. J Endocrinol 2005;184:291–318.
   PubMed Web of Science ®Google Scholar
• Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I, Akil H, et al. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci 1999;19:RC26.
   PubMedGoogle Scholar
• Bewick GA, Gardiner JV, Dhillo WS, Kent AS, White NE, Webster Z, Ghatei MA, Bloom SR. Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J 2005;19:1680–1682.
   PubMed Web of Science ®Google Scholar
• Belgardt BF, Okamura T, Brüning JC. Hormone and glucose signalling in POMC and AgRP neurons. J Physiol (Lond) 2009;587:5305–5314.
   Google Scholar
• Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 2003;6:736–742.
   PubMed Web of Science ®Google Scholar
• Gooley JJ, Schomer A, Saper CB. The dorsomedial hypothalamic nucleus is critical for the expression of food-entrainable circadian rhythms. Nat Neurosci 2006;9:398–407.
   PubMed Web of Science ®Google Scholar
• Bailey EF. A tasty morsel: the role of the dorsal vagal complex in the regulation of food intake and swallowing. Focus on “BDNF/TrkB signaling interacts with GABAergic system to inhibit rhythmic swallowing in the rat,” by Bariohay et al. Am J Physiol Regul Integr Comp Physiol 2008;295:R1048–R1049.
   Google Scholar
• Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006;27:73–100.
   PubMed Web of Science ®Google Scholar
• Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004;28:640–648.
   PubMed Web of Science ®Google Scholar
• Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 1973;84:488–495.
   PubMed Web of Science ®Google Scholar
• Murphy KG, Dhillo WS, Bloom SR. Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev 2006;27:719–727.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007;117:13–23.
   PubMed Web of Science ®Google Scholar
• Chen J, Scott KA, Zhao Z, Moran TH, Bi S. Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration. Neuroscience 2008;152:178–188.
   PubMed Web of Science ®Google Scholar
• Boguszewski CL, Paz-Filho G, Velloso LA. Neuroendocrine body weight regulation: integration between fat tissue, gastrointestinal tract, and the brain. Endokrynol Pol 2010;61:194–206.
   Google Scholar
• Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005;85:495–522.
   PubMed Web of Science ®Google Scholar
• Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003;124:1325–1336.
   PubMed Web of Science ®Google Scholar
• Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 2003;88:3989–3992.
   PubMed Web of Science ®Google Scholar
• Ashby D, Bloom SR. Recent progress in PYY research–an update report for 8th NPY meeting. Peptides 2007;28:198–202.
   Google Scholar
• Moran TH, Dailey MJ. Minireview: Gut peptides: targets for antiobesity drug development? Endocrinology 2009;150:2526–2530.
   PubMed Web of Science ®Google Scholar
• Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res 2004;36:747–754.
   PubMed Web of Science ®Google Scholar
• Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 2004;145:2687–2695.
   PubMed Web of Science ®Google Scholar
• Reda TK, Geliebter A, Pi-Sunyer FX. Amylin, food intake, and obesity. Obes Res 2002;10:1087–1091.
   PubMedGoogle Scholar
• Rushing PA, Hagan MM, Seeley RJ, Lutz TA, Woods SC. Amylin: a novel action in the brain to reduce body weight. Endocrinology 2000;141:850–853.
   PubMed Web of Science ®Google Scholar
• Blüher S, Mantzoros CS. Leptin in humans: lessons from translational research. Am J Clin Nutr 2009;89:991S–997S.
   PubMed Web of Science ®Google Scholar
• Paz-Filho GJ, Volaco A, Suplicy HL, Radominski RB, Boguszewski CL. Decrease in leptin production by the adipose tissue in obesity associated with severe metabolic syndrome. Arq Bras Endocrinol Metabol 2009;53:1088–1095.
   PubMedGoogle Scholar
• Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002;346:570–578.
   PubMed Web of Science ®Google Scholar
• Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006;443:289–295.
   PubMed Web of Science ®Google Scholar
• Schwartz MW, Porte D Jr. Diabetes, obesity, and the brain. Science 2005;307:375–379.
   PubMed Web of Science ®Google Scholar
• Kyrou I, Chrousos GP, Tsigos C. Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci 2006;1083:77–110.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci 2006;1083:111–128.
   PubMed Web of Science ®Google Scholar
• Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 1997;46:717–719.
   PubMed Web of Science ®Google Scholar
• Duclos M, Marquez Pereira P, Barat P, Gatta B, Roger P. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes Res 2005;13:1157–1166.
   PubMedGoogle Scholar
• Weigensberg MJ, Toledo-Corral CM, Goran MI. Association between the metabolic syndrome and serum cortisol in overweight Latino youth. J Clin Endocrinol Metab 2008;93:1372–1378.
   PubMed Web of Science ®Google Scholar
• Abraham NG, Brunner EJ, Eriksson JW, Robertson RP. Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes. Ann N Y Acad Sci 2007;1113:256–275.
   Google Scholar
• Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000;24 Suppl 2:S50–S55.
   PubMed Web of Science ®Google Scholar
• Lindmark S, Lönn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obes Res 2005;13:717–728.
   PubMedGoogle Scholar
• Lee ZS, Critchley JA, Tomlinson B, Young RP, Thomas GN, Cockram CS, Chan TY, Chan JC. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metab Clin Exp 2001;50:135–143.
   PubMedGoogle Scholar
• Huggett RJ, Scott EM, Gilbey SG, Bannister J, Mackintosh AF, Mary DA. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 2005;48:172–179.
   PubMedGoogle Scholar
• Huggett RJ, Hogarth AJ, Mackintosh AF, Mary DA. Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus. Diabetologia 2006;49:2741–2744.
   PubMed Web of Science ®Google Scholar
• Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH, Vogelzangs N, et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010;95:2458–2466.
   PubMed Web of Science ®Google Scholar
• Frontoni S, Bracaglia D, Baroni A, Pellegrini F, Perna M, Cicconetti E, Ciampittiello G, et al. Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 2003;41:1223–1227.
   Google Scholar
• Holt RI. Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 2002;13:392–397.
   PubMedGoogle Scholar
• Brick DJ, Gerweck AV, Meenaghan E, Lawson EA, Misra M, Fazeli P, Johnson W, et al. Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity. Eur J Endocrinol 2010;163:185–191.
   PubMed Web of Science ®Google Scholar
• Osterstock G, Escobar P, Mitutsova V, Gouty-Colomer LA, Fontanaud P, Molino F, Fehrentz JA, et al. Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus. PLoS ONE 2010;5:e9159.
   Google Scholar
• Hana V, Silha JV, Justova V, Lacinova Z, Stepan JJ, Murphy LJ. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clin Endocrinol (Oxf) 2004;60:442–450.
   Google Scholar
• Tung YC, Ma M, Piper S, Coll A, O’Rahilly S, Yeo GS. Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus. J Neurosci 2008;28:12419–12426.
   Google Scholar
• Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 2005;289:E266–E271.
   Google Scholar
• Klieverik LP, Coomans CP, Endert E, Sauerwein HP, Havekes LM, Voshol PJ, Rensen PC, et al. Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology 2009;150:5639–5648.
   Google Scholar
• Choi YH, Hartzell D, Azain MJ, Baile CA. TRH decreases food intake and increases water intake and body temperature in rats. Physiol Behav 2002;77:1–4.
   Google Scholar
• Ishii S, Kamegai J, Tamura H, Shimizu T, Sugihara H, Oikawa S. Triiodothyronine (T3) stimulates food intake via enhanced hypothalamic AMP-activated kinase activity. Regul Pept 2008;151:164–169.
   Google Scholar
• Ghamari-Langroudi M, Vella KR, Srisai D, Sugrue ML, Hollenberg AN, Cone RD. Regulation of thyrotropin-releasing hormone-expressing neurons in paraventricular nucleus of the hypothalamus by signals of adiposity. Mol Endocrinol 2010;24:2366–2381.
   Google Scholar
• Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 2002;87:2391–2394.
   PubMed Web of Science ®Google Scholar
• Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398–401.
   PubMed Web of Science ®Google Scholar
• Allan CA, McLachlan RI. Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol (Oxf) 2004;60:653–670.
   PubMed Web of Science ®Google Scholar
• Brown LM, Clegg DJ. Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 2010;122:65–73.
   PubMed Web of Science ®Google Scholar
• Andersson B, Mattsson LA, Hahn L, Mårin P, Lapidus L, Holm G, Bengtsson BA, Björntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:638–643.
   PubMed Web of Science ®Google Scholar
• Lee CC, Kasa-Vubu JZ, Supiano MA. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women. Metab Clin Exp 2004;53:507–512.
   PubMed Web of Science ®Google Scholar
• Santollo J, Eckel LA. Estradiol decreases the orexigenic effect of neuropeptide Y, but not agouti-related protein, in ovariectomized rats. Behav Brain Res 2008;191:173–177.
   Google Scholar
• Clegg DJ, Brown LM, Zigman JM, Kemp CJ, Strader AD, Benoit SC, Woods SC, et al. Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats. Diabetes 2007;56:1051–1058.
   PubMed Web of Science ®Google Scholar
• Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006;55:978–987.
   PubMed Web of Science ®Google Scholar
• Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001;25:1680–1688.
   PubMed Web of Science ®Google Scholar
• Rivier C, Rivier J, Vale W. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 1986;231:607–609.
   PubMed Web of Science ®Google Scholar